|
|
| The Next Frontier In mRNA | Webinar | Cytiva | Explore constructing a modular RNA-LNP GMP facility using an integrated, flexible process train in a turnkey modular environment to scale RNA-LNP therapies. |
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Barreling through the initial months of the year? Here’s a suggestion from Chief Editor Louis Garguilo to pump the breaks for a bit. Take one more glance in the rearview mirror to assess your current progress, reconfirm your pathway is your intended one. An outsourcing pause might pay off handsomely this year, and that’s because a lot happened last year on the supply-chain front. You made plans and formed expectations based on those trends and experiences. Are you currently abiding by those analyses? | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Partnering For Success In Oncolytic Virus Development | Article | By Michael Baker, FUJIFILM Biotechnologies | Learn how to navigate decision-making at critical steps and find solutions to key challenges in process development and scale-up to expedite oncolytic virus programs. |
|
|
|
| Viral Vectors: The Backbone Of Cell And Gene Therapy | Article | Landmark Bio | Viral vectors are the indispensable backbone of genetic medicine. View the fundamental trade-offs and manufacturing strategies for large-scale production of AAV and lentiviral delivery systems. |
|
|
| New Technology Platforms Being Developed | Q&A | Vector BioMed | New tools and technologies are reshaping drug development, enabling faster discovery, better scalability, and greater precision across biologics and advanced therapies. |
|
|
|
| Navigating Lentiviral Therapy Commercialization | Poster | By Jiasong Jiang, Leila M. Aneke, F. Michael Haller, et al., Lonza | Review the results obtained for our proprietary HEK293T 2G7 suspension cell line for LVV production by transient transfection in serum-free, chemically-defined, and animal component-free media. |
|
|
| Time: A Crucial Factor In Therapeutics Development | Article | Aldevron | Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability. |
|
|
| Revolutionizing Gene Therapy Manufacturing | Webinar | Thermo Fisher Scientific | By integrating perfusion into upstream manufacturing, see how this approach has achieved up to a fivefold increase in productivity, delivering titers that significantly exceed current industry benchmarks. |
|
|
|
|
One-Step Large Knock-In Technology | Applied StemCell | Identify a one-step gene-editing method designed to streamline the integration of large DNA sequences into cells. This technology increases editing, reduces timelines, and improves the reliability of cell lines. |
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
